Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma.

Lisa P SpeesStephanie B WheelerBradford E JacksonChristopher D BaggettLauren E WilsonMelissa A GreinerDeborah R KayeTian ZhangDaniel GeorgeCharles D ScalesJessica E PritchardMichael LeapmanCary P GrossMichaela A Dinan

Published in: Cancer medicine (2021)

Our results suggest that provider- and patient-level factors influence OAA initiation in patients with mRCC but only insurance type was associated with adherence.

Keyphrases

metastatic renal cell carcinoma
primary care
case report
type diabetes
healthcare
health insurance
adipose tissue
metabolic syndrome
skeletal muscle
weight loss
affordable care act